Fixed drug eruption related to sunitinib: a case report

A Rare Case of Fixed Drug Eruption due to Ondansetron

AbstractFixed drug eruption (FDE) is a unique type of cutaneous drug reaction that typically recurs in the identical locations on re-exposure to the attributed drug. FDE is characterized by the appearance of a single or multiple sharply demarcated violaceous erythematous plaques which heal with residual hyperpigmentation. A 27-year-old woman presented with multiple dark patches over her eyelids...

Fixed Drug Eruption Due to Ornidazole - A Case Report

Fixed Drug Eruption (FDE) is classified as cutaneous drug reaction which recurs in the same locations upon systemic administration of the same drug. Vesicles and bullae may sometimes be found, and in some cases even these are confused with Stevens Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN). A male patient, 62 years old, developed FDE with the use of ornidazole. On physical exami...

Fixed Drug Eruption Due to Fluconazole: a Case Report

Fluconazole is commonly used in treatment of candidiasis and dermatophyte infections. Fluconazole-induced fixed drug eruption (FDE) is one of the rare adverse cutaneous drug reactions reported in literature. We report a case of a 23-year-old man who developed FDE after intake of fluconazole, which resolved after the drug was discontinued. Thus, for safe use of medicines, continued reporting of ...

Fixed drug eruption due to etoricoxibe - a case report.

Fluconazole - a case report on fixed drug eruption

Background Adverse reactions to drugs, Fixed Erythema (FE), correspond to 16-21% of all skin eruptions. This disease results in the development of one or more erythematous annular or oval, plaques as a result of systemic exposure to a drug. On reexposure relapse occurs in the same place, although new lesions may arise simultaneously in other areas. Any drug can cause FE. The physiopathology inv...